Impact of glycemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation.

Toshinori HiraiYoshihiko MorikawaRitsuki OnishiYusuke NakataniKouhei NishikawaTakahiro InoueTakuya Iwamoto

Published in: British journal of clinical pharmacology (2023)

HbA1c and CYP3A5 genotypes might be considered to understand the inter- and intra-individual variability in blood tacrolimus concentrations after 6 months post kidney transplantation.

Keyphrases

kidney transplantation
glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
metabolic syndrome
skeletal muscle